Stroke is a leading cause of death and disability worldwide. Imaging plays a critical role in
evaluating patients suspected of acute stroke and transient ischemic attack, especially …

For decades, imaging has been a critical component of the diagnostic evaluation and
management of patients suspected of acute ischemic stroke (AIS). With each new advance …

This review summarizes the current state of knowledge regarding the use of imaging to
guide stroke treatment. Brain imaging plays a central role in the diagnosis of stroke and …

Society of Neuroradiology, and the Foundation of the American Society of Neuroradiology
sponsored a series of working group meetings> 12 months, with the final meeting occurring …

Acute imaging for evidence-based treatment of ischemic strok... : Current Opinion in
Neurology Acute imaging for evidence-based treatment of ischemic stroke : Current Opinion …

Worldwide, stroke is a leading cause of death and disability. Recombinant tissue
plasminogen activator (rtPA) was approved a decade ago for the treatment of acute ischemic …

Reperfusion therapy for acute stroke has evolved from the initial use of intravenous tissue
plasminogen activator (tPA) within 3 hours of symptom onset to more recent guideline …

Acute ischemic stroke (AIS) is among the leading causes of death and long-term disability.
Intravenous tissue plasminogen activator has been the mainstay of acute therapy. Recently …

The number of potential patients who are actually treated for acute ischemic stroke is
disappointingly low, and effective treatments are making a minor impact on this major public …

This review summarizes the modern early diagnosis and acute phase treatment of acute
stroke. The guidelines for treatment of acute ischemic stroke underwent major changes in …